Global Point-of-Care Testing (POCT) Market – New Report by Data Bridge Market Research

Global Point-of-Care Testing (POCT) Market – New Report by Data Bridge Market Research

Global Point-of-care Testing (POCT) Market Trends and Forecast to 2024 – By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others), Prescription Mode, Distribution Channel, End User, By Geography

Dallas, TX, December 16, 2016 –(PR.com)– The market for Global Point-of-care Testing (POCT) is expected to reach USD 38.2 billion by 2024 from USD 18.5 billion in 2016, growing 9.5% during the forecast years 2017 to 2024.

The global point-of-care testing (POCT) market is segmented based on product, prescription mode, distribution channel, end user and geography.

Request for sample pages: http://databridgemarketresearch.com/reports/global-point-care-testing-poct-market-trends-forecast-2024/

On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others. Cardiometabolic Monitoring Kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections), respiratory infections testing kits, others. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.

Based on prescription mode, the market is segmented into prescription based testing and over-the-counter (OTC) testing.

On the basis of distribution channel, the market is segmented into direct tenders and retail.

Based on end–user the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market is further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.

Read more: http://databridgemarketresearch.com/reports/global-point-care-testing-poct-market-trends-forecast-2024/

The major players operating in this market are Abbott Laboratories, Inc., Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, AccuBioTech Co., Ltd., bioMérieux, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical.

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.